Get the Stockscreener App
127.05
0.31%
-0.40
After Hours:
125.90
-1.15
-0.91%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $127.05, with a volume of 2.34M.
It is down -0.31% in the last 24 hours and up +6.20% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$127.45
Open:
$126.73
24h Volume:
2.34M
Relative Volume:
1.07
Market Cap:
$30.95B
Revenue:
$222.16B
Net Income/Loss:
$1.31B
P/E Ratio:
23.70
EPS:
5.36
Net Cash Flow:
$-486.00M
1W Performance:
-0.94%
1M Performance:
+6.20%
6M Performance:
+27.66%
1Y Performance:
+22.08%
1-Day Range:
$125.74
$127.19
1-Week Range:
$122.86
$128.56
52-Week Range:
$93.17
$132.84
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
127.05 | 30.95B | 222.16B | 1.31B | -486.00M | 5.36 |
|
MCK
Mckesson Corporation
|
599.75 | 77.79B | 330.19B | 2.54B | 4.31B | 19.31 |
|
COR
Cencora Inc
|
246.13 | 47.71B | 293.96B | 1.51B | 3.00B | 7.51 |
|
HSIC
Henry Schein Inc
|
79.85 | 9.32B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.03 | 2.72B | 6.55B | 155.22M | -823.13M | 1.71 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
Spire Wealth Management Purchases 5,733 Shares of Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Pharmaceuticals Wholesale & Distribution Market to grow by USD 896.5 Billion from 2024-2028, Driven by Growing Global Pharmaceutical Sales, Report on How AI is Driving Market Transformation - Benzinga
Burford Brothers Inc. Acquires Shares of 10,617 Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Stock Yards Bank & Trust Co. Reduces Position in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health Q3 EPS Forecast Reduced by Leerink Partnrs - MarketBeat
Cardinal Health raised to buy by Jefferies - MSN
Cardinal Health raises FY25 EPS guidance to $7.85-$8 amid specialty growth and acquisitions - MSN
Cardinal Health raised to buy by Jefferies (CAH:NYSE) - Seeking Alpha
Cardinal Health to Open New Distribution Center in Ft. Worth - Construction Equipment Guide
Radioactive Tracer Market Generated Opportunities, Future Scope by 2032 | PerkinElmer Inc., Cardinal Health, - EIN News
This NXP Semiconductors Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Yousif Capital Management LLC Has $13.08 Million Position in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Avitas Wealth Management LLC Buys Shares of 12,395 Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Jefferies Upgrades Cardinal Health to Buy From Hold, Adjusts Price Target to $150 From $140 - Marketscreener.com
Cardinal Health’s Growth Potential Under New Management: Buy Rating Backed by Strong Earnings and Strategic Acquisitions - TipRanks
abrdn plc Has $85.40 Million Stock Holdings in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health, Inc. (NYSE:CAH) Announces Quarterly Dividend of $0.51 - MarketBeat
Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings - Benzinga
JPMorgan Chase & Co. Raises Cardinal Health (NYSE:CAH) Price Target to $145.00 - MarketBeat
Cardinal Health (NYSE:CAH) Price Target Raised to $136.00 at Wells Fargo & Company - MarketBeat
JPMorgan Adjusts Price Target on Cardinal Health to $145 From $142, Maintains Neutral Rating - Marketscreener.com
Cardinal Health Second Quarter 2025 Earnings: EPS Beats Expectations - Simply Wall St
A fourth Dublin high school? District exploring purchasing part of Cardinal Health HQ - AOL
Columbus Macro LLC Has $2.17 Million Stock Position in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
IntelBroker Strikes HPE Again, Cardinal Health Breach, and U.S. ISP Root Access Sale - SOCRadar
Healthcare Distribution Market Set to Witness Significant Growth by 2025-2032: Consorta, Inc., Cardinal - EIN News
Cardinal Health (NYSE:CAH) Stock Price Down 4.1%Should You Sell? - MarketBeat
Traders Purchase Large Volume of Cardinal Health Put Options (NYSE:CAH) - MarketBeat
Sivik Global Healthcare LLC Has $5.91 Million Stake in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Mediolanum International Funds Ltd Acquires 4,001 Shares of Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health (NYSE:CAH) Posts Quarterly Earnings Results, Beats Expectations By $0.19 EPS - MarketBeat
Pacer Advisors Inc. Has $4.28 Million Stock Holdings in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Morgan Stanley Issues Positive Forecast for Cardinal Health (NYSE:CAH) Stock Price - MarketBeat
Cardinal Health Keeps Quarterly Dividend at $0.5056 a Share, Payable April 15 to Investors of Record April 1 - Marketscreener.com
Cardinal Health Board of Directors Approves Quarterly Dividend - Nasdaq
Dublin City Schools cancels plan to buy Cardinal Health building for $37 million - NBC4 WCMH-TV
Cardinal Health’s Strategic Maneuvering and Strong Core Execution Earns ‘Buy’ Rating - TipRanks
Cardinal Health (NYSE:CAH) Price Target Raised to $142.00 - Defense World
Avantra Family Wealth Inc. Makes New $881,000 Investment in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Independence Bank of Kentucky Increases Stock Position in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Swedbank AB - MarketBeat
Investors Buy Large Volume of Cardinal Health Put Options (NYSE:CAH) - Defense World
Rep. Marjorie Taylor Greene Purchases Shares of Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Mizuho raises Cardinal Health stock target to $142, keeps Outperform - MSN
Cardinal Health may raise prices to offset potential tariffs - MSN
Cardinal Health price target raised to $150 from $144 at TD Cowen - Yahoo Finance
Oak Harvest Investment Services Makes New Investment in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Kingswood Wealth Advisors LLC Acquires New Position in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Wells Fargo & Company Raises Cardinal Health (NYSE:CAH) Price Target to $135.00 - MarketBeat
Cardinal Health’s Earnings Call: Growth Amid Challenges - TipRanks
Cardinal Health Inc. stock underperforms Friday when compared to competitors - MarketWatch
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.82%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):